# Assessment of AI Program 'DRISTi' as a Screening Tool

> **NCT07222293** · — · RECRUITING · sponsor: **Artelus AI** · enrollment: 900 (estimated)

## Conditions studied

- Diabetic Retinopathy (DR)

## Interventions

- **DIAGNOSTIC_TEST:** Fundus Image Grading

## Key facts

- **NCT ID:** NCT07222293
- **Lead sponsor:** Artelus AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-23
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222293, "Assessment of AI Program 'DRISTi' as a Screening Tool". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07222293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*